Home › Funds › ABSOLUTE INVESTMENT ADVISERS, LLC › PCRX

ABSOLUTE INVESTMENT ADVISERS, LLC position in PCRX

PACIRA BIOSCIENCES INC · Health Care

ABSOLUTE INVESTMENT ADVISERS, LLC reported holding 11,500,000 shares of PCRX (PACIRA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$11.3M, representing 1.31% of its reported portfolio and ranking #25 among its reported holdings. ABSOLUTE INVESTMENT ADVISERS, LLC has disclosed PCRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)11.50M sh
Reported value held$11.31M
Portfolio Weight1.31%
First reportedQ2 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ABSOLUTE INVESTMENT ADVISERS, LLC's PCRX position evolved

ABSOLUTE INVESTMENT ADVISERS, LLC first disclosed a stake in PCRX in Q2 2025 at 7,000,000 shares (US$6.8M). The position peaked in Q3 2026 at 11,500,000 shares, worth US$11.3M. Across 6 filings, ABSOLUTE INVESTMENT ADVISERS, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 11,500,000 shares valued at US$11.3M — an increase of 2,500,000 shares quarter over quarter.. Notable position changes include a 28% increase in Q3 2026 (shares rose 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 7.00M $6.84M New
Q3 2025 8.00M $8.09M Add
Q4 2025 9.00M $9.07M Add
Q1 2026 9.00M $8.70M Hold
Q2 2026 9.00M $9.04M Hold
Q3 2026 11.50M $11.31M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCRX and 13F data

PCRX (PACIRA BIOSCIENCES INC) is a Health Care company. 21 other funds we track also report a position in PCRX — the largest reported positions include Context Capital Management, LLC (US$87.0M), Doma Perpetual Capital Management LLC (US$70.5M), GAGNON SECURITIES LLC (US$15.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCRX

All PCRX fund holders →

FAQ

How long has ABSOLUTE INVESTMENT ADVISERS, LLC held PCRX?

ABSOLUTE INVESTMENT ADVISERS, LLC has disclosed PCRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is ABSOLUTE INVESTMENT ADVISERS, LLC's current position in PCRX?

As of Q3 2026, ABSOLUTE INVESTMENT ADVISERS, LLC holds 11.50M shares of PCRX (PACIRA BIOSCIENCES INC), valued at $11.31M, representing 1.31% of its reported portfolio and ranking #25.

Has ABSOLUTE INVESTMENT ADVISERS, LLC been buying or selling PCRX?

In the latest 13F filing (Q3 2026), ABSOLUTE INVESTMENT ADVISERS, LLC increased its position in PCRX. The position peaked in Q3 2026 at 11.50M shares.

Which other funds hold PCRX?

Other major institutional holders of PCRX include Context Capital Management, LLC, Doma Perpetual Capital Management LLC, GAGNON SECURITIES LLC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.